○Toyoda Kazunori1, Koga Masatoshi1, Yamamoto Haruko2, Sato Shoichiro1, Fukuda-Doi Mayumi3, Sakai Nobuyuki4, Hara Takayuki5, Daniel F Hanley6, Yuko Y Palesch7, Adnan I Qureshi8, the ATACH-2 Trial Investigators9 (1. Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, 2. Center for Advancing Clinical and Translational Sciences, National Cerebral and Cardiovascular Center, 3. Department of Data Science, National Cerebral and Cardiovascular Center, 4. Department of Neurosurgery, Kobe City Medical Center General Hospital, 5. Department of Neurosurgery, Toranomon Hospital, 6. Division of Brain Injury Outcomes, Johns Hopkins University, 7. Department of Public Health Sciences, Medical University of South Carolina, 8. Zeenat Qureshi Stroke Research Center, University of Minnesota, 9. the ATACH-2 Trial Investigators)
Session information
Late Breaking Symposium
[LB] Late Breaking Symposium
Sat. May 26, 2018 3:00 PM - 5:00 PM Room 5 (Sapporo Geibunkan / Seiryu (3F))
Chair: Ichiro Yabe(Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University)
○Uchida Yuto1,2, Kan Hirohito3, Arai Nobuyuki3, Kawashima Shoji1, Ueki Yoshino4, Matsukawa Noriyuki1 (1. Department of Neurology, Nagoya City University, 2. Department of Neurology Toyokawa City Hospital, 3. Department of Radiology, Nagoya City University Hospital, 4. Department of Rehabilitation Medicine, Nagoya City University)
○Abe Hiroki1, Jitsuki Susumu1, Nakajima Waki1, Murata Yumi2, Jitsuki-Takahashi Aoi1, Katsuno Yuki1, Tada Hirobumi1, SanoAkane1, Suyama Kumiko1, Mochizuki Nobuyuki1,3,4, Komori Takashi1,3,4, Masuyama Hitoshi1,3,4, Okuda Tomohiro3,4, Goshima Yoshio5, Higo Noriyuki2, Takahashi Takuya1 (1. Yokohama City University Graduate School of Medicine, Department of Physiology, 2. HumanInformatics Research Institute, National Institute of Advanced Industrial Science and Technology, 3. Toyama Chemical Co, 4. Fujifilm Corporation, 5. Yokohama City University Graduate School of Medicine, Department of Molecular Pharmacology and Neurobiology)
○Yabe Ichiro1, YaguchiHiroaki1, Kato Yasutaka2, Miki Yasuo3, Takahashi Hidehisa4, Shirai Shinichi1,Takahashi Ikuko1, Fujioka Shinsuke5, Watanabe Masashi4, NakagawaShin6, Kunieda Yasuyuki7, Ikeda Yoshio8, Hasegawa Masato9, Nishihara Hiroshi2, Ohtsuka Toshihisa10, TanakaShinya2, Tsuboi Yoshio5, Hatakeyama Shigetsugu4, Wakabayashi Koichi3, Sasaki Hidenao1 (1. Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, 2. Department of Cancer Pathology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, 3.Department of Neuropathology, Hirosaki University Graduate School of Medicine, 4. Department of Biochemistry, Faculty of Medicine and Graduate School of Medicine, 5. Department of Neurology, Fukuoka University School of Medicine, 6. Department of Psychiatry, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, 7. Wakkanai City Hospital, 8. Department of Neurology, Gunma University Graduate School of Medicine, 9. Department of Dementia and Higher Brain Function, Tokyo Metropolitan Institute of Medical Science, 10. Department of Biochemistry, Faculty of Medicine / Graduate School of Medicine, University of Yamanashi)